Application | Comment | Organism |
---|---|---|
medicine | plasma variations of different types of XIIa following thrombolytic treatment analyzed | Homo sapiens |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
additional information | - |
plasma variations of different forms of XIIa analyzed by ELISA assays | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P00748 | coagulation factor XII, precursor; patients with acute ST-elevation myocardial infarction (STEMI), treated with thrombolytic therapy | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
blood | venous blood samples | Homo sapiens | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
changes of plasma variations of different types of XIIa in relation to thrombolytic therapy by administration of tenecteplase (TNK-tpa), a thrombolytic with a high fibrin specify, blood samples obtained prior to, within, and four days after administration of thrombolytic therapy, ELISA assays measuring different types of XIIa described | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | changes of plasma variations of different types of XIIa measured followed by thrombolytic therapy of patients with acute ST-elevation myocardial infarction | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
coagulation factor XIIa | - |
Homo sapiens |